Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Afr J Prim Health Care Fam Med ; 13(1): e1-e3, 2021 Feb 15.
Article in English | MEDLINE | ID: covidwho-1089009

ABSTRACT

The coronavirus disease 2019 (COVID-19) pandemic has spread throughout the world, with devastating effects of the virus as well as the repercussions of the resulting 'lockdowns'. South Africa went into a national lockdown in March 2020 to mitigate the impact of the virus. This included a ban on the sales of tobacco and electronic cigarette products. The ban has been a highly contentious issue in South Africa, discussed worldwide, which has drawn many criticisms. The prevalence rate of smoking in South Africa was around 21.5%, with the Western Cape province having a prevalence rate of 39%. We compared the number of chronic obstructive pulmonary disease (COPD) presentations at a large regional referral hospital in the Western Cape province from January to August 2019 with the same period in 2020. Electronic emergency centre data showed a reduction of 69.28% in COPD presentations. To control for some confounders for the same period, we also reviewed patients presenting with urinary tract infections, which showed only a 30.60% reduction. This notable reduction in COPD presentations reduced service pressure of emergency centre and most likely benefitted patients' health. Further research and policies are needed to ensure ongoing reduction in the prevalence of smoking.


Subject(s)
COVID-19 , Cigarette Smoking/adverse effects , Emergency Service, Hospital , Pandemics , Patient Acceptance of Health Care/statistics & numerical data , Pulmonary Disease, Chronic Obstructive/therapy , Tobacco Products/legislation & jurisprudence , COVID-19/epidemiology , COVID-19/prevention & control , COVID-19/virology , Cigarette Smoking/epidemiology , Cigarette Smoking/legislation & jurisprudence , Cigarette Smoking/prevention & control , Commerce/legislation & jurisprudence , Communicable Disease Control/methods , Humans , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/epidemiology , SARS-CoV-2 , South Africa/epidemiology , Symptom Flare Up , Tobacco Products/adverse effects , Tobacco Products/economics
SELECTION OF CITATIONS
SEARCH DETAIL